Previous study showed that NEAT1 knockdown activated AMPK signaling pathway in free fatty acids-treated HepG2 cells, a cell model of nonalcoholic fatty liver disease [28]. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.